 |
 |

Cutaneous Hypoxia in Patients With Systemic Sclerosis (Scleroderma)
Judith L. Silverstein, MD;
Virginia D. Steen, MD;
Thomas A. Medsger, Jr, MD;
Vincent Falanga, MD
Arch Dermatol. 1988;124(9):1379-1382.
Abstract
 |  |
Measurement of transcutaneous oxygen pressure (Tcpo2) is an established and noninvasive way of assessing cutaneous hypoxia. Since the degree of oxygénation modulates fibroblast growth and synthesis, we investigated the presence of cutaneous hypoxia in patients with systemic sclerosis (SS). We measured Tcpo2 of the involved skin of the dorsal aspect of the forearm in 33 patients with SS and 16 control individuals (normal subjects and patients with Raynaud's disease). The degree of forearm skin thickness was assessed clinically as mild, moderate, or severe. The Tcpo2 measurements were obtained at a sensor temperature of 44°C, which causes maximal vasodilation and eliminates the variables associated with vascular tone. Measurements were recorded while patients were breathing room air or 31% oxygen delivered by a Ventimask system (Baxter Healthcare, Ocala, Fla). We also measured the Tcpo2 of the medial aspect of the arm when this site was uninvolved. We found that sclerodermatous skin is hypoxic when compared with the uninvolved skin of patients with SS or control individuals. The Tcpo2 values were indirectly related to skin thickness; thus, patients whose skin was severely thickened had the lowest Tcpo2 values. There was no correlation of Tcpo2 values with pulmonary function tests or arterial oxygen pressure. The Tcpo2 levels of patients with Raynaud's disease did not differ from other control individuals. The administration of oxygen increased Tcpo2 readings in patients with SS to normal values. We conclude that the thickened skin of patients with SS is hypoxic and suggest that Tcpo2 measurements may be helpful in objectively assessing the degree of skin thickness. The hypoxia demonstrated in SS skin may play a role in the modulation of dermal fibroblast proliferation and synthetic activity.
(Arch Dermatol 1988;128:1379-1382)
Author Affiliations
From the Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine (Dr Falanga) and the Departments of Dermatology (Dr Silverstein) and Medicine (Drs Steen and Medsger), University of Pittsburgh School of Medicine.
Footnotes
Accepted for publication April 5, 1988.
Reprint requests to Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, PO Box 016250 (R-250), Miami, FL 33101 (Dr Falanga).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Scleroderma
Gabrielli et al.
NEJM 2009;360:1989-2003.
FULL TEXT
Transforming Growth Factor-beta Receptor Type I-dependent Fibrogenic Gene Program Is Mediated via Activation of Smad1 and ERK1/2 Pathways
Pannu et al.
J. Biol. Chem. 2007;282:10405-10413.
ABSTRACT
| FULL TEXT
Hypoxia and Transforming Growth Factor-{beta}1 Act Independently to Increase Extracellular Matrix Production by Placental Fibroblasts
Chen et al.
J. Clin. Endocrinol. Metab. 2005;90:1083-1090.
ABSTRACT
| FULL TEXT
Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron
Ryter et al.
Am. J. Physiol. Heart Circ. Physiol. 2000;279:H2889-H2897.
ABSTRACT
| FULL TEXT
Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts
Panchenko et al.
Am. J. Physiol. Cell Physiol. 2000;278:C92-C101.
ABSTRACT
| FULL TEXT
Egr-1 Mediates Transcriptional Activation of IGF-II Gene in Response to Hypoxia
Bae et al.
Cancer Res. 1999;59:5989-5994.
ABSTRACT
| FULL TEXT
Hypoxia downregulates tropoelastin gene expression in rat lung fibroblasts by pretranslational mechanisms
Berk et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 1999;277:L566-L572.
ABSTRACT
| FULL TEXT
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
Lee et al.
J. Biol. Chem. 1997;272:5375-5381.
ABSTRACT
| FULL TEXT
Transcutaneous Oxygen and Carbon Dioxide Measurement in Peripheral Vascular Disease
Melillo et al.
VASC ENDOVASCULAR SURG 1995;29:273-280.
ABSTRACT
|